| A bistable genetic switch based on designable DNA-binding domains T Lebar, U Bezeljak, A Golob, M Jerala, L Kadunc, B Pirš, M Stražar, ... Nature communications 5 (1), 5007, 2014 | 89 | 2014 |
| A synthetic mammalian therapeutic gene circuit for sensing and suppressing inflammation A Smole, D Lainšček, U Bezeljak, S Horvat, R Jerala Molecular therapy 25 (1), 102-119, 2017 | 53 | 2017 |
| Stochastic activation and bistability in a Rab GTPase regulatory network U Bezeljak, H Loya, B Kaczmarek, TE Saunders, M Loose Proceedings of the National Academy of Sciences 117 (12), 6540-6549, 2020 | 29 | 2020 |
| Cancer gene therapy goes viral: viral vector platforms come of age U Bezeljak Radiology and Oncology 56 (1), 1-13, 2022 | 21 | 2022 |
| Self-organization in a Rab GTPase regulatory network U Bezeljak, L Kowalski, H Loya, B Kaczmarek, B Wu, JA Servin, ... FEBS OPEN BIO 11, 21-21, 2021 | | 2021 |
| In vitro reconstitution of a Rab activation switch U Bezeljak | | 2020 |
| Priprava in optimizacija cepljenih inteinov za nadzorovanje povezovanja proteinskih domen: magistrsko delo U Bezeljak U. Bezeljak, 2015 | | 2015 |
| Bistable genetic toggle switch comprising a pair of reciprocal repressors and a positive feedback loop based on dna-binding proteins R Jerala, M BENČINA, A Majerle, A OBLAK, T LEBAR, V FORSTNERIČ, ... | | 2014 |
| Mehanizem aktivacije receptorskega kompleksa TLR4/MD2 s kovinskimi ioni U Bezeljak U. Bezeljak, 2013 | | 2013 |
| Prikazovanje tkiva z masno spektrometrijo M Bratuš, U Bezeljak, V Frančič | | |
